About Omnitrope®

Omnitrope® is an injectable medication containing human growth hormone (HGH), a naturally occurring hormone that begins to decline after the age of 30.  Although Omnitrope® has not been approved by the FDA for fertility treatment, studies have shown that it may improve egg quality in women with low levels of natural HGH. It is usually prescribed to women classified as “poor responders”, such as those over the age of 40,  those with diminished ovarian reserve (low egg count), or those who responded poorly to prior treatment with stimulation medications. Omnitrope® is typically taken as a daily subcutaneous (under the skin) injection for approximately 8-12 days as a supplement to your stimulation medications (Follistim AQ®, Gonal-f®, or Menopur®).

Omnitrope® comes in a 5.8mg multiple dose vial of powdered medication that must be mixed with bacteriostatic water before injecting.

Download Instruction Guide

If you have questions after watching these videos, please call 1-800-515-DRUG (3784) to speak to an MDR Pharmacist.